Of the 574 RCC samples, the MTAP/CDKN2AMUT significantly predicted extremely poor PFS [hazard ratio (HR)=7.705, P < 0.0001] and OS (HR = 6.369, P < 0.0001; Figure 1D). This evidence concerns the gene MTAP and renal cell carcinoma.